image
Apellis Pharmaceuticals, Inc. APLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 17.78
-5.89 %
$ 2.23 B
Market Cap
-9.68
P/E
BALANCE SHEET
885 M ASSETS
12.21%
Growth Rates
1Year 12.21%
3Years 0.12%
5Years 17.86%
7Years 25.34%
10Years 51.06%
657 M LIABILITIES
10.49%
Growth Rates
1Year 10.49%
3Years -1.31%
5Years 13.08%
7Years 53.17%
10Years 89.81%
229 M EQUITY
17.49%
Growth Rates
1Year 17.49%
3Years 4.78%
5Years 46.19%
7Years 6.31%
10Years 32.97%
BALANCE SHEET DECOMPOSITION
Balance Sheet Apellis Pharmaceuticals, Inc.
image
Current Assets 789 M
Cash & Short-Term Investments 411 M
Receivables 272 M
Other Current Assets 106 M
Non-Current Assets 96.1 M
Long-Term Investments 0
PP&E 19 M
Other Non-Current Assets 77.1 M
46.47 %30.70 %11.97 %8.71 %Total Assets$885.1m
Current Liabilities 186 M
Accounts Payable 38.6 M
Short-Term Debt 6.75 M
Other Current Liabilities 140 M
Non-Current Liabilities 471 M
Long-Term Debt 463 M
Other Non-Current Liabilities 7.97 M
5.88 %21.35 %70.53 %Total Liabilities$656.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 411.3 351.2 551.8 640.2 565.8 352.0 176.3 175.6 24.9 36.0 13.6 4.8
Short Term Investments 0 1.1 6.5 60.4 311.9 0 0 0 0 0 0 0
Receivables 271.7 206.4 7.7 10.1 25.0 0 0 0 0 0 0.5 67.2 K
Inventory 81.4 146.4 85.7 16.3 0 0 0 0 0 0 0.1 0.3
Other Current Assets 24.5 61.2 73.0 97.1 14.5 21.1 26.2 6.4 2.5 2.0 0.2 0.4
Total Current Assets 789.0 766.3 719.5 824.0 917.2 373.1 202.4 182.0 27.4 38.0 14.2 5.2
PP&E 19.0 21.1 24.9 26.1 24.5 15.8 1.0 0 0 0 21.7 K 9.13 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 3.2 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 77.1 (1.9) 15.8 31.6 18.9 0.4 0.1 0.1 64.5 K 0.1 37.2 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 885.1 788.7 760.2 881.8 960.6 389.2 203.5 182.1 27.4 38.2 14.3 5.2
LIABILITIES
Accounts Payable 38.6 37.5 37.3 16.9 8.5 8.4 10.3 3.7 2.5 2.5 0.8 0.4
Short Term Debt 6.8 6.4 5.6 4.1 3.7 5.2 1.7 0 0 0 0 0
Other Current Liabilities 140.2 203.6 124.6 110.8 116.2 52.2 5.1 2.9 1.1 0.7 0.3 0.3
Total Current Liabilities 185.5 247.6 167.6 131.8 128.3 65.8 17.0 6.6 3.6 3.2 1.1 0.7
Long Term Debt 463.0 104.5 107.1 206.1 374.0 154.4 25.4 26.4 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 8.0 242.1 315.6 345.2 253.6 134.8 0.2 0.2 0 0 0 0
Total Liabilities 656.5 594.2 590.3 683.1 756.0 355.0 42.6 33.2 3.6 3.2 1.1 0.7
EQUITY
Common Stock 12 K 12 K 11 K 10 K 8 K 6.39 K 5.63 K 5.03 K 843 843 978 978
Retained Earnings (3 035.4) (2 837.5) (2 308.9) (1 656.7) (926.3) (581.5) (276.8) (149.3) (98.3) (71.1) (24.6) (13.8)
Other Accumulative Comprehensive Income/Loss (3.3) (3.5) (0.9) (2.1) (0.1) (0.2) (0.1) 0 0 0 21.5 K 15.6 K
Total Equity 228.5 194.5 169.9 198.7 204.6 34.2 161.0 148.9 23.8 35.0 13.2 4.5
Total Liabilities and Equity 885.1 788.7 760.2 881.8 960.6 389.2 203.5 182.1 27.4 38.2 14.3 5.2
SHARES OUTSTANDING
Common Shares Outstanding 123.9 118.7 106.1 84.4 75.2 62.2 54.4 13.9 18.1 18.1 18.1 18.1